Received Jun 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | UNK | — |
Fainted; Vomiting; decreased heart rate; decreased blood pressure; Accidental underdose; This serious case was reported by a nurse via sales rep and described the occurrence of fainting in a patient who received Men ACWY-CRM NVS (Menveo) solution for injection for prophylaxis. On an unknown date, the patient received the 1st dose of Menveo (unknown arm). On an unknown date, an unknown time after receiving Menveo, the patient experienced fainting (Verbatim: Fainted) (serious criteria GSK medically significant), vomiting (Verbatim: Vomiting), heart rate decreased (Verbatim: decreased heart rate), blood pressure decreased (Verbatim: decreased blood pressure) and accidental underdose (Verbatim: Accidental underdose). The outcome of the fainting and vomiting were resolved and the outcome of the heart rate decreased and blood pressure decreased were not reported and the outcome of the accidental underdose was not applicable. It was unknown if the reporter considered the fainting, vomiting, heart rate decreased and blood pressure decreased to be related to Menveo. The company considered the fainting to be unrelated to Menveo. Additional Information: GSK Receipt Date:16-JUN-2026 The batch number was not provided upon follow up with the reporter.; Sender's Comments: A case of Syncope, on an unknown time after vaccination with unknown dose of Menveo, in a patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.